NCT06281795

Brief Summary

There are few studies in the literature that have evaluated the effects of using percutaneous stimulation of the auricular branch of the vagus nerve for sports purposes (to accelerate recovery after physical exertion). It has been demonstrated that tVNS in athletes improved the rate of heart rate recovery, reduced lactic acid levels in blood plasma, reduced pain, reduced overtraining syndrome and fatigue levels.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

1.8 years

First QC Date

February 19, 2024

Last Update Submit

June 23, 2025

Conditions

Keywords

auricular stimulationauricular vagus nerve stimulationtranscutaneous vagus nerve stimulation (tVNS)vagus nerve stimulation (VNS)heart rateheart rate variabilitypower of high-frequency oscillations (HF)power of low-frequency oscillations (LF)LF/HFindex centralization (IC)index of vegetative balance (IVB)athletessportmaximum oxygen consumption (VO2max)treadmill speedanaerobic threshold of metabolism.aerobic metabolism threshold of metabolism

Outcome Measures

Primary Outcomes (2)

  • Dynamics of maximum oxygen consumption (VO2max).

    During a cardiorespiratory exercise test, the level of VO2max (ml/min/kg) is assessed.

    The level of VO2max is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and fictitious stimulation groups.

  • The dynamics of the treadmill speed at the level of the anaerobic threshold of metabolism.

    During the cardiorespiratory exercise test, the treadmill speed (km/h) is estimated at the level of the anaerobic metabolic threshold.

    Treadmill speed is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.

Secondary Outcomes (6)

  • Dynamics of the treadmill speed at the level of the aerobic metabolism threshold of metabolism.

    Treadmill speed is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.

  • The dynamics of the heart rate (HR) at the level of the anaerobic threshold of metabolism.

    HR is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.

  • The dynamics of the heart rate (HR) at the level of the aerobic threshold of metabolism.

    HR is estimated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the active and dummy stimulation groups.

  • The dynamics of RMSSD.

    This parameter is evaluated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the groups of active and fictitious stimulation.

  • HF dynamics

    This parameter is evaluated at the beginning of the study (initially) and at the end of the study (after 8 weeks) in the groups of active and fictitious stimulation.

  • +1 more secondary outcomes

Study Arms (2)

Active tVNS

ACTIVE COMPARATOR

Active stimulation will be carried out using the tVNS device with an ear clip attached to the tragus of the left ear at a frequency of 20 Hz, 200 μs at a current slightly below the discomfort threshold. The device's operating mode is active therapeutic.

Device: tVNS

Sham tVNS

SHAM COMPARATOR

Fictitious stimulation will be carried out using the tVNS device with an ear clip attached to the tragus of the left ear at a frequency of 20 Hz, 200 μs at a current slightly below the discomfort threshold. The device's operating mode is research mode.

Device: tVNS

Interventions

tVNSDEVICE

tVNS will be performed daily after workouts for 60 minutes over a period of 8 weeks.

Active tVNSSham tVNS

Eligibility Criteria

Age15 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Professional athletes over the age of 15 and under the age of 35;
  • Cyclic sports (swimming, modern pentathlon, athletics, triathlon);
  • Difficult coordination sports (dance sports, rhythmic gymnastics);
  • Sports category: no lower than candidate for master of sports;
  • Voluntary informed consent.

You may not qualify if:

  • Atypical and unrelated to physical exertion changes on the ECG (T wave inversion, st-segment depression, pathological Q waves, signs of left atrial enlargement, signs of right ventricular hypertrophy, ventricular pre-excitation, complete right or left bundle branch block, prolonged or shortened Q-T interval, Brugada-like early repolarization);
  • Heart rhythm and conduction disorders (frequent ventricular and supraventricular extrasystoles, first-degree atrioventricular block (P-Q \> 0.21 s, not shortened during hyperventilation or physical exertion), second or third degree);
  • Expressed sinus bradycardia with resting heart rate \< 40 bpm;
  • Taking glucocorticosteroids in the last 1 month;
  • Taking any antiarrhythmic drugs, including beta-blockers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPION

Krasnodar, Russia

RECRUITING

Related Links

MeSH Terms

Conditions

FatigueMental FatigueCombat Disorders

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Vasiliy Danilov

    Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPION

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1:1 randomization of active stimulation vs. sham stimulation
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, DM, Professor

Study Record Dates

First Submitted

February 19, 2024

First Posted

February 28, 2024

Study Start

April 1, 2024

Primary Completion

January 31, 2026

Study Completion

January 31, 2026

Last Updated

June 26, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations